589. Oral Tablet Vaccination Induces Heightened Cross-Reactive CD8 T Cell Responses to SARS-COV-2 in Humans

por Johnson, Susan, Martinez, Clarissa, Cortese, Mario, Martinez, Josefina, Garg, Shaily, Peinovich, Nadine, Dora, Emery, Tucker, Sean
Publicado 2021

Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2

por Braun, Molly R., Martinez, Clarissa I., Dora, Emery G., Showalter, Laura J., Mercedes, Annette R., Tucker, Sean N.
Publicado 2023

1960. Mucosal rAd5 Immunization against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in African Green...

por Flitter, Becca A, Tedjakusuma, Sarah N, Lester, Colin A, Neuhaus, Elena D, Johnson, Susan, Dora, Emery G, Peinovich, Nadine, Jegede, Clara B, Tucker, Sean N
Publicado 2022

Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model

por Langel, Stephanie N., Johnson, Susan, Martinez, Clarissa I., Tedjakusuma, Sarah N., Peinovich, Nadine, Dora, Emery G., Kuehl, Philip J., Irshad, Hammad, Barrett, Edward G., Werts, Adam, Tucker, Sean N
Publicado 2022